TBCE and keratoconus: First, to investigate the delivery of Exo-srIκB by KCs, we labeled Exo-srIκB with DiI and treated to mouse primary KCs in time (1 or 3 h)- and dose (KC:Exo-srIκB = 1:1000 or 1:10,000)-dependent manners.